logo
科言猫学术研究的AI总结
language
手机端手机端
  • Phone Feature微信小程序
简体中文简体中文
notice消息通知
博客博客
delete
arrow
返回
L

Li Zhang

Shanghai Jiao Tong University

52H指数
455论文数
1.4W被引数
收录论文 118
发表时间
logo
Cascade-targeted intervention of the NLRP3 inflammasome and downstream angiogenesis by curcumin nanoparticles for ocular neovascularization therapy姜黄素纳米颗粒级联靶向干预NLRP3炎性小体及其下游血管生成，用于眼部新生血管治疗
errClinical and Translational Medicine
IF6.8
err2026-09-23
err0
errOAAI
errSiyu Jiang; Ziwei Cheng; Yujuan Cai; Yanji Zhu; Nyamjargal Nyambayar; Ruijie Lin; Li Zhang; Jian Chen; Bing Xie; Xiuping Chen
err分享
err收藏
Lumbar stiffness complaints, stiffness-related disability, and low back pain in relation to patient satisfaction: a cross-sectional analysis across different postoperative stages
errJournal of Orthopaedic Surgery and Research
IF2.8
err2026-09-14
err0
errOAAI
errYudong Zhao; Li Zhang; LongJie Wang; TianChang Wang; HongBin He; ShengXi Jin; Siyu Zhou; Weishi Li
err分享
err收藏
Iron-addicted colorectal cancers exploit heme-complex II axis to resist oxidative cell death铁依赖性结直肠癌利用血红素-复合物II轴抵抗氧化性细胞死亡
errCell Metabolism
IF30.9
err2026-05-27
err0
errOAAI
errChesta Jain; Muqit Essani; Roshan Kumar; Nupur K. Das; Rashi Singhal; Nicholas J. Rossiter; Brandon Chen; Wesley Huang; Zheng Hong Lee; Sumeet Solanki; Yuezhong Zhang; Peter Sajjakulnukit; Li Zhang; Prarthana J. Dalal; David A. Hanna; Cristina Castillo; Harrison S. Greenbaum; Shannon E. McCollum; Elena M. Stoffel; Joel K. Greenson
err分享
err收藏
Treatment options and considerations for acquired resistance in EGFR mutation-positive non-small-cell lung cancerEGFR突变阳性非小细胞肺癌获得性耐药的治疗选择及注意事项
errESMO Open
IF8.3
err2026-01-27
err0
errOAAI
errX. Le; S. Popat; J.V. Heymach; H. West; L. Zhang
err分享
err收藏
When Obesity Meets Lymphedema: Interaction Effects on Lymphatic Pain Among Chinese Breast Cancer Survivors当肥胖遇上淋巴水肿：中国乳腺癌幸存者中淋巴疼痛的交互作用效应
errClinical Breast Cancer
IF2.5
err2025-12-18
err0
PREAI
errAomei Shen; Yuhua Yang; Li Zhang; Nada Lukkahatai; Mei R Fu; Shengwen Dong; Ying Wang; Hongmeng Zhao; Peipei Wu; Pan Yang; Qian Lu
err分享
err收藏
Uridine-cytidine kinase 2 as a novel potential prognostic and therapeutic biomarker in gastric cancer尿苷胞苷激酶2作为胃癌的新型潜在预后和治疗生物标志物
errTranslational Cancer Research
IF1.7
err2025-11-30
err0
PREAI
errSun, Weilin; Guo, Hui; Cai, Mingzhi; Ma, Gang; Zhang, Li; Yu, Yang; Zhan, Hongjie
err分享
err收藏
Health-related quality of life among anaplastic lymphoma kinase (ALK)-positive non-small cell lung cancer (NSCLC) patients treated with first- and next-generation ALK tyrosine kinase inhibitors (TKIs): a systematic review and meta-analysis与健康相关的生活质量在间变性淋巴瘤激酶（ALK）阳性非小细胞肺癌（NSCLC）患者中使用第一代和下一代ALK酪氨酸激酶抑制剂（TKIs）治疗：一项系统评价和荟萃分析
errQuality of Life Research
IF2.7
err2025-11-28
err0
errOAAI
errYan Huang; Qian Chu; Jiejun Wang; Li Zhang
err分享
err收藏
The effects of short- and long-duration Kangaroo Mother Care and conventional care on improving weight gain in low birth weight infants: a systematic review and meta-analysis短程与长程袋鼠式母亲护理及常规护理对改善低出生体重儿体重增长的影响：一项系统评价和荟萃分析
errBMC PEDIATRICS
IF2
err2025-11-10
err0
errOAAI
errGong, Zhijia; He, Jiao; Zhang, Li
err分享
err收藏
\zaAlectinib versus crizotinib in previously untreated ALK-positive advanced non-small cell lung cancer: Final overall survival analysis of the Phase III ALEX study阿来替尼对比克唑替尼用于初治ALK阳性晚期非小细胞肺癌：III期ALEX研究最终总生存期分析
errAnnals of Oncology
IF65.4
err2025-10-17
err0
errOAAI
errS. Peters; R. Camidge; R. Dziadziuszko; S. Gadgeel; A.T. Shaw; D-W. Kim; M. Pérol; D.R. Rosell; P. Cheema; D.Wan-Teck Lim; J.J. Lin; N. Pavlakis; J.S. Ahn; L. Zhang; V. Henschel; A.A. Higgerson; V. McNally; I. Rooney; A. Scalori; V. Smoljanovic; T. Mok
err分享
err收藏
Association of metabolic syndrome and prognosis in elderly patients with community-acquired pneumonia代谢综合征与社区获得性肺炎老年患者预后的关系
errBMC Pulmonary Medicine
IF2.8
err2025-10-15
err0
errOAAI
errXiaofeng Tang; Li Zhang; Ruijuan Wu; Jie Liu; Yongfeng Cheng
err分享
err收藏
A novel tRNA-derived small RNA, 5'tiRNA-Gln-TTG-001, aggravates cardiomyocyte inflammatory injury through upregulation of CLIC4一种新型的tRNA衍生小RNA，5'tiRNA-Gln-TTG-001，通过上调CLIC4加剧心肌细胞炎症损伤。
errMOLECULAR MEDICINE REPORTS
IF3.5
err2025-10-01
err0
errOAAI
errWang, Jing; Yi, Yingchun; Han, Bo; Zhang, Li; Jia, Hailin
err分享
err收藏
Impact of anesthesia precision intervention on perioperative serum myocardial injury markers and major adverse cardiac events in high-risk cardiovascular patients undergoing non-cardiac surgery麻醉精准干预对高风险心血管患者非心脏手术围术期血清心肌损伤标志物和主要不良心脏事件的影响
errJOURNAL OF INVESTIGATIVE MEDICINE
IF2
err2025-10-01
err0
PREAI
errZhang, Li; Zhai, Haoyu; Zeng, Heng; Qiu, Liya; Huang, Rong
err分享
err收藏
Consolidative nivolumab versus observation in unresectable stage III non-small cell lung cancer patients following neoadjuvant nivolumab plus chemotherapy and concurrent chemoradiotherapy (CA209-7AL): a randomized clinical trial巩固性尼沃鲁单抗与观察对比在不可切除III期非小细胞肺癌患者中的应用，这些患者接受新辅助尼沃鲁单抗联合化疗及同步放化疗后（CA209-7AL）：一项随机临床试验
errSignal Transduction and Targeted Therapy
IF52.7
err2025-09-29
err0
errOAAI
errBo Qiu; Yuanyuan Zhao; Wenzhuo He; Weijin Zeng; Hongmei Zhang; Weineng Feng; Jun Jia; Daodu Wang; Daquan Wang; Fangjie Liu; Songran Liu; Shaohan Yin; Chuanmiao Xie; Rui Zhou; Yi Hu; Qianwen Liu; Jinyu Guo; Suping Guo; Yingjia Wu; Qiaoting Luo; Jibin Li; Yunpeng Yang; Liangping Xia; Li Zhang; Hui Liu
err分享
err收藏
Pharmacokinetics, safety, and efficacy of mixed formulation of fosrolapitant and palonosetron (HR20013) in combination with dexamethasone in patients with solid tumors scheduled for highly emetogenic cisplatin-based chemotherapy: a phase I trialHR20013（fosrolapitant和palonosetron的混合制剂）与地塞米松联合用药在拟接受高度催吐性顺铂为基础化疗的实体瘤患者中的药代动力学、安全性与有效性：一项I期临床试验
errBMC Medicine
IF8.3
err2025-08-29
err0
errOAAI
errYuanyuan Zhao; Yuxiang Ma; Tengrui Yin; Zhiquan Qin; Linlin Liu; Guoqiang Kong; Ranran Zhang; Yuanyuan Huang; Li Zhang; Hongyun Zhao
err分享
err收藏
First-line sacituzumab tirumotecan with tagitanlimab in advanced non-small-cell lung cancer: a phase 2 trial一线sacituzumab tirumotecan联合tagitanlimab治疗晚期非小细胞肺癌：一项Ⅱ期临床试验
errNature Medicine
IF50
err2025-08-19
err0
PREAI
errShaodong Hong; Qiming Wang; Ying Cheng; Yongzhong Luo; Xiujuan Qu; Haibo Zhu; Zhenyu Ding; Xingya Li; Lin Wu; Yan Wang; Sheng Hu; Enwen Wang; Anwen Liu; Yuping Sun; Yun Fan; Feng Ye; Kaihua Lu; Jian Fang; Yuping Shen; Xiaoping Jin; Junyou Ge; Li Zhang; Wenfeng Fang
err分享
err收藏
The next generation of immunotherapies for lung cancers肺癌的下一代免疫疗法
errNature Reviews Clinical Oncology
IF82.2
err2025-06-17
err0
PREAI
errShen Zhao; Hongyun Zhao; Weiwei Yang; Li Zhang
err分享
err收藏
Ovarian escape in premenopausal breast cancer: Challenges and strategies for optimizing hormone suppression绝经前乳腺癌患者的卵巢逃逸现象：优化激素抑制的挑战与策略
errCancer Treatment Reviews
IF10.5
err2025-05-25
err0
PREAI
errLan Luo; Yonglin Zhang; Li Zhang; Senguo Yang; Tian Zhou; Ke Luo; Shu Liu
err分享
err收藏
Evolutionary adaptation and asymmetric inheritance of polyploid giant cancer cells in esophageal squamous cell carcinoma食管鳞状细胞癌中多倍体巨癌细胞的选择性适应和不对称遗传
errCancer Letters
IF10.1
err2025-05-23
err0
PREAI
errSong, Qiqin; Gao, Mingwei; Weng, Yongjia; Zhuang, Xuehan; Wu, Yueguang; Cui, Heyang; Ding, Ning; Wang, Longlong; Bi, Shanshan; Zhang, Li; Zhang, Weimin; Cui, Yongping
err分享
err收藏
CCN1 is a therapeutic target upregulated in EML4-ALK mutant lung adenocarcinoma reversibly resistant to alectinibCCN1是治疗靶点，其在突变型EML4-ALK肺腺癌中对阿来替尼产生可逆性耐药时被上调。
errCELL DEATH & DISEASE
IF9.6
err2025-04-15
err0
errOAAI
errHuang, Yihua; Huang, Jie; Zhan, Jianhua; Chen, Maojian; Zheng, Jiani; He, Junyi; Fang, Wenfeng; Zhang, Li; Li, Jing
err分享
err收藏
Sacituzumab tirumotecan in advanced non-small-cell lung cancer with or without EGFR mutations: phase 1/2 and phase 2 trialsSacituzumab tirumotecan在有无EGFR突变晚期非小细胞肺癌中的研究：Ⅰ/Ⅱ期和Ⅱ期临床试验
errNATURE MEDICINE
IF50
err2025-04-10
err0
PREAI
errZhao, Shen; Cheng, Ying; Wang, Qiming; Li, Xingya; Liao, Jun; Rodon, Jordi; Meng, Xiangjiao; Luo, Yongzhong; Chen, Zhendong; Wang, Wei; Yi, Tienan; Li, Yongsheng; Yin, Yongmei; Xu, Huiting; Yu, Guohua; Mi, Yanjun; Fan, Yun; Wainberg, Zev A.; Wang, Xiang; Su, Cuiyun; Yu, Qitao; Lai, Shuzhen; Sun, Longhua; Zhuang, Wu; Wang, Xian; Yang, Jiacheng; Li, Yaling; Ge, Junyou; Li, Jin; Zhang, Li
err分享
err收藏

研究方向

暂时未获取到该数据
合作学者
合作期刊
J
James Chih‐Hsin Yang
H 指数: 141 · 论文数: 1.2K
J
James Moon
H 指数: 138 · 论文数: 1.4K
Y
Yi‐Long Wu
H 指数: 135 · 论文数: 2.2K
T
Tony Mok
H 指数: 131 · 论文数: 1.1K
张
张军 (Jun Zhang)
H 指数: 124 · 论文数: 4.5K
查看更多